To determine whether ASCT2 expression is increased in prostate cancer compared to normal tissue, we compared patient‐matched TCGA mRNA expression data for normal prostate versus prostate cancer (Figure 1A). This evidence concerns the gene SLC1A5 and prostate carcinoma.